Literature DB >> 23447654

SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.

Stéphanie Put1, Steve Schoonooghe, Nick Devoogdt, Evelien Schurgers, Anneleen Avau, Tania Mitera, Matthias D'Huyvetter, Patrick De Baetselier, Geert Raes, Tony Lahoutte, Patrick Matthys.   

Abstract

UNLABELLED: Rheumatoid arthritis (RA) is a chronic autoimmune disease occurring in approximately 1% of the worldwide population. The disease primarily affects the joints, where inflammatory cells, such as macrophages, invade the synovium and cause cartilage and bone destruction. Currently, it is difficult to efficiently diagnose and monitor early-stage RA. In this study, we investigated whether SPECT/micro-CT imaging with (99m)Tc-labeled Nanobodies directed against the macrophage mannose receptor (MMR) is a useful tool for monitoring and quantifying joint inflammation in collagen-induced arthritis (CIA), a mouse model for RA. The expression of MMR was analyzed on macrophages and osteoclasts generated in vitro and in cells obtained from various organs from mice with CIA.
METHODS: CIA was induced in DBA/1 mice by injection of collagen type II in complete Freund adjuvant, and cell suspensions from the inflamed joints and other organs were obtained. Macrophages and osteoclasts were generated in vitro from bone marrow cells. Expression of MMR was quantified by quantitative polymerase chain reaction and flow cytometry with specific Nanobodies and conventional antibodies. SPECT/micro-CT imaging was performed with (99m)Tc-labeled MMR and control Nanobodies.
RESULTS: MMR was highly expressed on macrophages and to a lesser extent on osteoclasts generated in vitro. In mice with CIA, MMR expression was detected on cells from the bone marrow, lymph nodes, and spleen. In synovial fluid of arthritic joints, MMR was expressed on CD11b(+)F4/80(+) macrophages. On in vivo SPECT/micro-CT imaging with consecutive injections of MMR and control Nanobodies, a strong MMR signal was seen in the knees, ankles, and toes of arthritic mice. Quantification of the SPECT imaging confirmed the specificity of the MMR signal in inflamed joints as compared with the control Nanobody. Dissection of the paws revealed an additional significant MMR signal in nonarthritic paws of affected mice (i.e., mice displaying symptoms of arthritis in other paws).
CONCLUSION: Our data show that MMR is expressed on macrophages in vitro and in vivo in synovial fluid of inflamed paws, whereas expression is relatively low in other tissues. The use of Nanobodies against MMR in SPECT/micro-CT imaging generates the possibility to track inflammatory cells in vivo in arthritic joints.

Entities:  

Keywords:  Nanobody; collagen-induced arthritis (CIA); macrophage mannose receptor (MMR); single photon emission computed tomography (SPECT)

Mesh:

Substances:

Year:  2013        PMID: 23447654     DOI: 10.2967/jnumed.112.111781

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  30 in total

1.  Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies.

Authors:  M Lemaire; M D'Huyvetter; T Lahoutte; E Van Valckenborgh; E Menu; E De Bruyne; P Kronenberger; U Wernery; S Muyldermans; N Devoogdt; K Vanderkerken
Journal:  Leukemia       Date:  2013-10-09       Impact factor: 11.528

Review 2.  Imaging Macrophage-associated Inflammation.

Authors:  Catherine A Foss; Julian Sanchez-Bautista; Sanjay K Jain
Journal:  Semin Nucl Med       Date:  2018-02-13       Impact factor: 4.446

3.  Evaluation of [99mTc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice.

Authors:  Gezim Bala; Henri Baudhuin; Isabel Remory; Kris Gillis; Pieterjan Debie; Ahmet Krasniqi; Tony Lahoutte; Geert Raes; Nick Devoogdt; Bernard Cosyns; Sophie Hernot
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

4.  Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics.

Authors:  Abul K Azad; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  J Cytol Mol Biol       Date:  2014-01-10

5.  Acid-Sensitive Sheddable PEGylated, Mannose-Modified Nanoparticles Increase the Delivery of Betamethasone to Chronic Inflammation Sites in a Mouse Model.

Authors:  Hannah L O'Mary; Abdulaziz M Aldayel; Solange A Valdes; Youssef W Naguib; Xu Li; Karun Salvady; Zhengrong Cui
Journal:  Mol Pharm       Date:  2017-05-10       Impact factor: 4.939

Review 6.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

Review 7.  Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.

Authors:  Marnix A Lameijer; Jun Tang; Matthias Nahrendorf; Robert H J Beelen; Willem J M Mulder
Journal:  Expert Rev Mol Diagn       Date:  2013-07       Impact factor: 5.225

8.  Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis.

Authors:  Fang Zheng; Amanda Sparkes; Patrick De Baetselier; Steve Schoonooghe; Benoit Stijlemans; Serge Muyldermans; Véronique Flamand; Jo A Van Ginderachter; Nick Devoogdt; Geert Raes; Alain Beschin
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

Review 9.  Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms.

Authors:  Nairo Brilhante-da-Silva; Rosa Maria de Oliveira Sousa; Andrelisse Arruda; Eliza Lima Dos Santos; Anna Carolina Machado Marinho; Rodrigo Guerino Stabeli; Carla Freire Celedonio Fernandes; Soraya Dos Santos Pereira
Journal:  Mol Diagn Ther       Date:  2021-06-19       Impact factor: 4.074

Review 10.  Nanobodies for Medical Imaging: About Ready for Prime Time?

Authors:  Léa Berland; Lauren Kim; Omar Abousaway; Andrea Mines; Shruti Mishra; Louise Clark; Paul Hofman; Mohammad Rashidian
Journal:  Biomolecules       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.